Bank of New York Mellon Corp - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$4,047,000
+57.8%
119,720
+9.1%
0.00%0.0%
Q1 2021$2,565,000
-19.9%
109,689
-1.3%
0.00%0.0%
Q4 2020$3,201,000
+49.4%
111,130
+5.0%
0.00%0.0%
Q3 2020$2,143,000
-26.6%
105,806
+8.9%
0.00%0.0%
Q2 2020$2,919,000
+51.9%
97,145
+58.8%
0.00%0.0%
Q1 2020$1,922,000
-20.2%
61,165
+19.7%
0.00%0.0%
Q4 2019$2,408,000
+1025.2%
51,116
+54.3%
0.00%
Q3 2019$214,000
-52.0%
33,131
-8.8%
0.00%
Q2 2019$446,000
-13.7%
36,330
-4.9%
0.00%
Q1 2019$517,00038,2100.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders